Author Question: Firms will continue to increase their purchase of factor inputs as long as ________. A) the ... (Read 44 times)

Hungry!

  • Hero Member
  • *****
  • Posts: 1,071
Firms will continue to increase their purchase of factor inputs as long as ________.
 
  A) the marginal product of a given factor is greater than its real factor price
  B) the marginal cost of a given factor is lower than its marginal product
  C) their total revenues are greater than their total costs
  D) all of the above
  E) none of the above

Question 2

How might strict adherence to the Taylor rule discourage cost-push inflation?
 
  What will be an ideal response?



kaylee05

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

D

Answer to Question 2

Cost-push inflation cannot persist without repeated increases in AD to counter declines in output. Constrained by the Taylor rule, monetary policy must tighten as the inflation rate rises, even when that means an increase in the (absolute value of the) output gap. Moreover, public knowledge of the central bank's commitment to an inflation target causes upward shifts of the aggregate supply curve to be relatively infrequent and small.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

In the ancient and medieval periods, dysentery killed about ? of all babies before they reach 12 months of age. The disease was transferred through contaminated drinking water, because there was no way to adequately dispose of sewage, which contaminated the water.

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library